1) 安達木綿子:小児のてんかん原性疾患top10.画像診断 26:981-991,2006
2) Burkhard PR, Sanchez JC, Landis T, et al:CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 56:1528-1533, 2001
3) Carpenter SS, Hatchett AD, Fuller MA:Catatonic schizophrenia and the use of memantine. Ann Pharmacother 40:344-346, 2006
4) Gastaut H, Poirier F, Payan H, et al:H.H.E.syndrome;Hemiconvulsion, hemiplegia, epilepsy. Epilepsia 1:418-447, 1959/60
5) Hong KS, Cho YJ, Jeong SW, et al:Diffusion changes suggesting predominant vasogenic oedema during partialis status epilepticus. Seizure 13:317-321, 2004
6) Jentsch JD, Roth RH:The neuropsychopharmacology of phencyclidine:From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201-225, 1999
7) 松浦雅人,梶浦真由,坂井禎一郎,他:HHE症候群の脳波.精神科治療学 13:1173-1177,1998
8) Mory Y:Anatomopathology and pathogeny of the hemiconvulsion-hemiplegia-epilepsy syndrome. J Neurosurg Sci 22:17-28, 1978
9) Salih MA, Kabiraj M, Al-Jarallah AS, et al:Hemiconvulsion-hemiplegia-epilepsy syndrome. A clinical, electroencephalographic and neuroradiologocal study. Child's Nerv Syst 13:257-263, 1997
10) Selakovic V, Raicevic R, Radenovic L:The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. J Clin Neurosci 12:542-547, 2005
11) Senn P, Lövblad KO, Zutter D, et al:Changes on diffusion-weighted MRI with focal motor status epilepticus. Neuroradiology 45:246-249, 2003
12) Takahashi Y, Mori H, Mishina M, et al:Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology 61:891-896, 2003
13) Takahashi Y:Infections as causative factors of epilepsy. Future Neurol 1:291-302, 2006
14) Thomas C, Carroll BT, Maley RT, et al:Memantine and catatonic schizophrenia. Am J Psychiatry 162:626, 2005
15) Viala K, Chabriat H, Brunereau L, et al:Hemicerebral atrophy and epilepsy in an adult. Rev Neurol(Paris) 154:45-50, 1998